全文获取类型
收费全文 | 381384篇 |
免费 | 43524篇 |
国内免费 | 12575篇 |
专业分类
耳鼻咽喉 | 2929篇 |
儿科学 | 5620篇 |
妇产科学 | 6760篇 |
基础医学 | 40713篇 |
口腔科学 | 5195篇 |
临床医学 | 34133篇 |
内科学 | 43332篇 |
皮肤病学 | 3000篇 |
神经病学 | 8251篇 |
特种医学 | 10678篇 |
外国民族医学 | 327篇 |
外科学 | 44209篇 |
综合类 | 55861篇 |
现状与发展 | 51篇 |
一般理论 | 28篇 |
预防医学 | 21420篇 |
眼科学 | 4422篇 |
药学 | 32553篇 |
169篇 | |
中国医学 | 14026篇 |
肿瘤学 | 103806篇 |
出版年
2024年 | 727篇 |
2023年 | 6282篇 |
2022年 | 9987篇 |
2021年 | 17509篇 |
2020年 | 16139篇 |
2019年 | 15151篇 |
2018年 | 14606篇 |
2017年 | 15216篇 |
2016年 | 16225篇 |
2015年 | 17700篇 |
2014年 | 26442篇 |
2013年 | 27232篇 |
2012年 | 22456篇 |
2011年 | 23849篇 |
2010年 | 18817篇 |
2009年 | 18794篇 |
2008年 | 19014篇 |
2007年 | 19642篇 |
2006年 | 17583篇 |
2005年 | 15856篇 |
2004年 | 13474篇 |
2003年 | 11569篇 |
2002年 | 9153篇 |
2001年 | 8731篇 |
2000年 | 7186篇 |
1999年 | 6369篇 |
1998年 | 4941篇 |
1997年 | 4424篇 |
1996年 | 4097篇 |
1995年 | 3832篇 |
1994年 | 3275篇 |
1993年 | 2806篇 |
1992年 | 2457篇 |
1991年 | 2142篇 |
1990年 | 1750篇 |
1989年 | 1614篇 |
1988年 | 1488篇 |
1987年 | 1193篇 |
1986年 | 906篇 |
1985年 | 1066篇 |
1984年 | 1012篇 |
1983年 | 658篇 |
1982年 | 755篇 |
1981年 | 662篇 |
1980年 | 574篇 |
1979年 | 453篇 |
1978年 | 344篇 |
1977年 | 287篇 |
1976年 | 300篇 |
1975年 | 199篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
TAKAKO EGUCHI TAKUJI GOTODA ICHIRO ODA HISANAO HAMANAKA NORIAKI HASUIKE DAIZO SAITO 《Digestive endoscopy》2003,15(2):113-116
Background: Endoscopic mucosal resection (EMR) is widely accepted as a minimally invasive treatment for early gastric cancer (EGC) in Japan. However, the criteria for EMR must be strictly adhered to otherwise patients will miss the chance for additional therapy. We assess the important factor in expanding the indication of EMR. Methods: We investigated 1101 EGCs that had been resected by EMR at the National Cancer Center Hospital (NCCH), Tokyo, Japan, according to the indication recommended by Japanese Gastric Cancer Association (JGCA) and the expanded indication proposed by NCCH. Curability and local recurrence of the EMRs were assessed related to the applied indication and the number of resected specimens. Results: The recurrence rate of non‐evaluable resection was higher than that of evaluable resection (P < 0.0001). Eighty‐three lesions among 772 lesions in the JGCA group were non‐evaluable. Thirty‐seven leisons among 329 lesions in the NCCH group were non‐evaluable. There was no difference in the rate of non‐evaluable resection between JGCA and NCCH groups (P = 0.8329). However, the rate of curative resection was lower in the NCCH group than in the JGCA group (P = 0.0009). In piecemeal resection, there was no difference in the rate of non‐evaluable resection between JGCA and NCCH groups (P = 0.0527). In one‐piece resection, the rate of non‐evaluable resection was lower in the NCCH group than the JGCA group (P = 0.0137). Conclusion: Based on our series of cases, we propose one‐piece resection as a gold standard for EMR because it enables accurate histological evaluation, even in the EMR, according to the expanded indication. 相似文献
992.
摘要:目的: 探讨内镜深筋膜下结扎交通支治疗下肢复发性静脉性溃疡的疗效。方法:手术治疗50例(56条)下肢复发性静脉性溃疡患者,行内镜下交通支静脉离断术,对术后溃疡愈合情况进行1~3年随访。 结果:55条下肢溃疡在10~49d内愈合,1条90d未愈,行小隐静脉高位结扎术后溃疡愈合。随访1~3年,6个月后复发1例,抗炎换药后愈合。18个月后2条复发,再行小隐静脉高位结扎术后溃疡愈合。 结论:腔镜深筋膜下交通支静脉结扎术安全有效,损伤小,并发症少,是治疗下肢复发性静脉性溃疡较为有效的方法。 相似文献
993.
腹腔镜胆囊切除术后残株胆囊及胆囊管结石 总被引:4,自引:0,他引:4
目的探讨腹腔镜胆囊切除术后残株胆囊/胆囊管结石的原因、诊断、处理及预防方法。方法回顾总结我院 1992-2005年间收治的8例腹腔镜胆囊切除术后残株胆囊/胆囊管结石病例的临床资料。结果 8例病人术前经B超、MRI、 ERCP检查确诊后,均经再次手术治愈。残株胆囊结石2例;残株胆囊管结石6例,其中2例合并胆总管结石;2例行残余胆囊切除术,6例行残株胆囊管切除、其中4例附加胆总管切开探查和/或取石、T型管引流。随访1.1-13年,效果良好。结论判断失误是腹腔镜胆囊切除术后残株胆囊结石的主要原因,过长的炎性及畸形的胆囊管残留是腹腔镜胆囊切除术后残株胆囊管结石的主要原因;其症状和体征类似于结石性胆囊炎、合并胆管结石时可有黄疸;B超、CT、ERCP等检查可确诊;再次手术切除(或取出)残株胆囊/胆囊管(结石)是有效可靠的治疗方法;娴熟的腹腔镜技术、术中胆道造影、正确掌握中转开腹指征以及丰富的胆道外科经验是预防其发生的关键。 相似文献
994.
蝎毒多肽提取物对肺癌荷瘤裸鼠血流变学的影响 总被引:2,自引:0,他引:2
目的观察蝎毒多肽提取物(PESV)对肺癌荷瘤裸鼠血流变学的影响。方法移植肺癌荷瘤裸鼠随机分为PESV组(皮下注射PESV)与对照组(皮下注射生理盐水)。采用FASCO-300型全自动表观黏度快测仪对两组的全血黏度进行检测。结果与对照组相比,PESV组血流变学指标均有不同程度的降低,尤其是全血低切表观黏度、全血高切表观黏度、Casson黏度、Casson屈服应力均明显低于对照组(P〈0.01)。结论PESV可降低荷瘤裸鼠血液黏度,对肺癌荷瘤裸鼠肿瘤转移能力有明显的抑制作用。 相似文献
995.
食管癌三维适形后程加速超分割放射治疗的疗效分析 总被引:3,自引:0,他引:3
目的评价三维适形后程加速超分割放射治疗食管癌的疗效及放疗反应、并发症。方法2002年2月至2004年5月,71例食管鳞癌随机分成两组,三维适形后程加速超分割组36例,食管病变上下外约4cm,前后、左右外约0.5~1cm作为PTV1,每次2GY,每周5次,DT40GY后,病变上下外约2cm,前后、左右外约0.5~1cm作为PTV2,每日2次,每次1.5GY,间隔4~6小时,总疗程6周,总剂量67GY/38次。非三维适形后程加速超分割组35例,时间、剂量、分割方式同适形组。所有病例均采用8MV-X外照射。结果1、2、3年的生存率和原发肿瘤的局控率,与非适形后程加速超分割比较,适形组明显提高,分别为88.9%、75%、63.9%比68.6%、51.4%、40%和86.1%、72.2%、58.3%比65.7%、48.5%、34.3%。适形组的急性放射反应明显低于非适形后程加速超分割组,两组有显著差别。结论本研究的初步结果表明食管癌适形后程加速超分割放射治疗的疗效优于非适形后程加速超分割组。 相似文献
996.
介入化疗结合立体适形放射治疗晚期胰腺癌的临床观察 总被引:1,自引:1,他引:0
探讨晚期胰腺癌的介入化疗加立体适形放射治疗的临床疗效。先选择性胰腺动脉化疗,药物:CF 300 mg、5-FU 1 000~1 500 mg、DDP 60~80 mg和健择1.2~2.0 g,共4次。介入化疗后或两次介入之间行立体定向放射治疗,放疗采用4~6个适形野,总剂量为35~45 Gy,4~8 Gy/次,每周3次,21例患者CR率42.85%(9/21),PR率42.85%(9/21),SD 4.76%(1/21),PD 9.52%(2/21),总有效率(CR PR)85.70%(18/21)。初步研究结果提示,主观指标评估,2例临床症状完全消失,17例主观症状有所改善。介入化疗结合立体放射治疗晚期胰腺癌不失为临床选用的治疗手段。 相似文献
997.
放射治疗71例骨转移癌止痛效果分析 总被引:2,自引:0,他引:2
目的观察低于常规剂量的2种分割方式治疗骨转移性疼痛的疗效。方法71例恶性肿瘤晚期骨转移患者,总计93处骨转移灶,根据疼痛程度及行动受限程度,采取2种均低于常规剂量的分割方式进行放射治疗,分别为Dm30Gy/10f/2W,Dm30Gy/6f/2W。观察疼痛缓解情况。结果2种分割方式止痛有效率分别为88%、95%。两组间无显著差异性(P>0.05)。与国内多数文献报告的结果接近。结论低于常规剂量的分割方式对转移性骨痛疗效与常规剂量的分割方式的疗效相当,且简便易行。 相似文献
998.
乳腺癌99mTc-MIBI影像与P-糖蛋白表达的相关性 总被引:4,自引:0,他引:4
为了探讨活体乳腺恶性肿瘤对99mTc-甲氧基异丁基异腈(99mTc-MIBI)的摄取和肿瘤细胞P-糖蛋白(P-glyco-protein,P-gp)表达间的关系。2003年10月~2005年12月对40例未经治疗的乳腺癌患者进行99mTc-MIBI早期(10min)与延迟(120min)平面显像,计算其外排率(WOR)。显像后1周内进行手术治疗或化疗,术后应用免疫组化方法检测肿瘤标本P-gp表达,结果进行统计学计算。结果:WOR在P-gp阳性者为(12.8±8.2)%,高于P-gp阴性者(1.2±6.2)%,差异有统计学意义,t=3.42,P=0.01;WOR与肿瘤大小成正相关。初步研究结果显示,乳腺恶性肿瘤对99mTc-MIBI的摄取与P-gp表达呈明显负相关,即肿瘤细胞高度表达P-gp时,99mTc-MIBI摄取较低,99mTc-MIBI显像和肿瘤细胞P-gp表达相关性好,可成为体内无创检测肿瘤组织P-gp表达及耐药性的重要手段。 相似文献
999.
H. GALLION W.A. CHRISTOPHERSON† R.L. COLEMAN‡ L. DEMARS§ T. HERZOG S. HOSFORD¶ H. SCHELLHAS# A. WELLS & B.-U. SEVIN†† 《International journal of gynecological cancer》2006,16(1):194-201
The study objective was to determine the effectiveness of a phenotypic chemoresponse assay in predicting response to chemotherapy measured by progression-free interval (PFI) in a retrospective series of ovarian cancer patients whose tumor specimens had been tested with the ChemoFx assay. A statistically significant correlation between assay prediction of response and PFI was observed in 256 cases with an exact or partial match between drug(s) assayed and received. In 135 cases with an exact match, the hazard ratio for progression of the resistant group was 2.9 (confidence interval [CI]: 1.4-6.3; P < 0.01) compared to the sensitive group and 1.7 (CI: 1.2-2.5) for the intermediate compared to the sensitive group. The median PFI for patients treated with drugs assayed as resistant was 9 months, 14 months for those with drugs assayed as intermediately sensitive, and PFI had not been achieved for those with drugs assayed as sensitive. These data indicate that the ChemoFx assay is predictive of PFI in ovarian cancer. As the majority of ovarian cancers display different degrees of response to different chemotherapy agents ex vivo, the incorporation of assay information into treatment selection has the potential to improve clinical outcomes in ovarian cancer patients. 相似文献
1000.
Arsenic trioxide–loaded, microemulsion-enhanced cytotoxicity on MDAH 2774 ovarian carcinoma cell line 总被引:2,自引:0,他引:2
M.C. TEREK B. KARABULUT† N. SELVI‡ L. AKMAN Y. KARASULU§ I. OZGUNEY§ A.U. SANLI† R. USLU† & A. OZSARAN 《International journal of gynecological cancer》2006,16(2):532-537
The antiproliferative effect of As(2)O(3)-loaded microemulsion (As(2)O(3)-M) on human MDAH 2774 ovarian cancer cells was compared with a regular solution of the As(2)O(3). We used MDAH 2774 as model cell lines for ovarian cancer. The (2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide) (XTT) and trypane blue dye exclusion tests were used to evaluate cytotoxicity. Apoptotic effect of solutions was evaluated using cell death detection kit. Standard microemulsion formulation used in this experiment contains 5 x 10(-6) M As(2)O(3). It was clearly demonstrated that As(2)O(3)-M had a significant cytotoxic effect on MDAH 2774 cell line, and the cytotoxic effect of As(2)O(3)-M was significantly higher than that of regular As(2)O(3) solutions. Even approximately 6000 times diluted microemulsion formulation loaded with 5 x 10(-6) M As(2)O(3) showed a cytotoxic effect. As a result, this diluted concentration (approximately 8 x 10(-10) M) was found to be approximately 6000 times more effective than regular As(2)O(3) solutions (5 x 10(-6) M). Moreover, this diluted concentration resulted in 1.5-fold enhancement of apoptosis. According to the in vitro cytotoxicity studies, we concluded that by incorporating As(2)O(3) into the microemulsion (As(2)O(3)-M), which is a new drug carrier system, it is possible to increase antiproliferative effect of regular As(2)O(3) on MDAH 2774 cells. Translating these results to in vivo conditions would open new windows in the treatment of ovarian cancer. 相似文献